Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Cephalomannine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101307040B details a novel NBS derivatization method for separating Paclitaxel from Cephalomannine, offering significant cost reduction in pharmaceutical intermediates manufacturing.
Patent CN101307040B details a novel NBS addition method for separating Paclitaxel from Cephalomannine, offering significant cost reduction in API manufacturing and high purity.
Patent CN102020619B reveals a mild 1,4-addition method for separating Cephalomannine from Taxol, offering high purity and cost-effective manufacturing for pharmaceutical intermediates.